Cargando…
KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) has very high prevalence and associated-mortality. However, targeted therapies that are currently used in clinical practice for HCC have certain limitations, in part because of the lack of reliable and clinically applicable biomarkers that can be used for d...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073891/ https://www.ncbi.nlm.nih.gov/pubmed/27769251 http://dx.doi.org/10.1186/s12885-016-2851-7 |